Author:
Jackson Mary Anne,Schutze Gordon E.,Byington Carrie L.,Maldonado Yvonne A.,Barnett Elizabeth D.,Campbell James D.,Davies H. Dele,Lynfield Ruth,Munoz Flor M.,Nolt Dawn,Nyquist Ann-Christine,O’Leary Sean,Rathore Mobeen H.,Sawyer Mark H.,Steinbach William J.,Tan Tina Q.,Zaoutis Theoklis E.,
Abstract
Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology and Child Health
Cited by
120 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献